Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Temozolomide (TEMODAR) in the Treatment of Adult Patients With Supratentorial Low Grade Glioma

NCT00313729 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00313729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00313729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Temozolomide (TEMODAR) in the Treatment of Adult Patients With Supratentorial Low Grade Glioma
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Completed
Start date
May 31, 1999
Completion date
June 12, 2017
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cns tumor, adult